ChromaDex Corporation's (NASDAQ:CDXC) 28% Cheaper Price Remains In Tune With Revenues

Simply Wall StDec 20 05:13 ET

Even Though ChromaDex (NASDAQ:CDXC) Has Lost US$73m Market Cap in Last 7 Days, Shareholders Are Still up 389% Over 1 Year

Yahoo FinanceDec 10 05:42 ET

Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)

TipRanksDec 8 03:40 ET · Ratings

Ladenburg Thalmann Maintains ChromaDex(CDXC.US) With Buy Rating, Raises Target Price to $6.8

Moomoo NewsDec 6 14:31 ET · Ratings

Roth MKM Maintains ChromaDex(CDXC.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsDec 6 09:31 ET · Ratings

Unwarranted Negative Reaction to ChromaDex 8-K a Buying Opportunity, Says Roth

TipRanksDec 6 08:49 ET